메뉴 건너뛰기




Volumn 5, Issue 7, 2010, Pages

R5 clade C SHIV strains with Tier 1 or 2 neutralization sensitivity: Tools to dissect env evolution and to develop AIDS vaccines in primate models

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS RNA;

EID: 77955490068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011689     Document Type: Article
Times cited : (47)

References (60)
  • 1
    • 33748650568 scopus 로고    scopus 로고
    • Molecularly cloned SHIV-1157ipd3N4: A highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C env
    • Song RJ, Chenine AL, Rasmussen RA, Ruprecht CR, Mirshahidi S, et al. (2006) Molecularly cloned SHIV-1157ipd3N4: a highly replication-competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C env. J Virol 80: 8729-8738.
    • (2006) J Virol , vol.80 , pp. 8729-8738
    • Song, R.J.1    Chenine, A.L.2    Rasmussen, R.A.3    Ruprecht, C.R.4    Mirshahidi, S.5
  • 3
    • 44049108744 scopus 로고    scopus 로고
    • Toward an AIDS vaccine
    • Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320: 760-764.
    • (2008) Science , vol.320 , pp. 760-764
    • Walker, B.D.1    Burton, D.R.2
  • 4
    • 38949195024 scopus 로고    scopus 로고
    • Broadening our view of protective antibody responses against HIV
    • Burke B, Barnett SW (2007) Broadening our view of protective antibody responses against HIV. Curr HIV Res 5: 625-641.
    • (2007) Curr HIV Res , vol.5 , pp. 625-641
    • Burke, B.1    Barnett, S.W.2
  • 5
    • 0037625131 scopus 로고    scopus 로고
    • Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
    • Pope M, Haase AT (2003) Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 9: 847-852.
    • (2003) Nat Med , vol.9 , pp. 847-852
    • Pope, M.1    Haase, A.T.2
  • 6
    • 12144289425 scopus 로고    scopus 로고
    • Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission
    • Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, et al. (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303: 2019-2022.
    • (2004) Science , vol.303 , pp. 2019-2022
    • Derdeyn, C.A.1    Decker, J.M.2    Bibollet-Ruche, F.3    Mokili, J.L.4    Muldoon, M.5
  • 7
    • 33751224478 scopus 로고    scopus 로고
    • Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
    • Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, et al. (2006) Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 80: 11776-11790.
    • (2006) J Virol , vol.80 , pp. 11776-11790
    • Li, M.1    Salazar-Gonzalez, J.F.2    Derdeyn, C.A.3    Morris, L.4    Williamson, C.5
  • 8
    • 73949127978 scopus 로고    scopus 로고
    • Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies
    • Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, et al. (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol 84: 1439-1452.
    • (2010) J Virol , vol.84 , pp. 1439-1452
    • Seaman, M.S.1    Janes, H.2    Hawkins, N.3    Grandpre, L.E.4    Devoy, C.5
  • 9
    • 0041828179 scopus 로고    scopus 로고
    • Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection
    • Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
    • (2003) AIDS , vol.17 , pp. 1871-1879
    • Fiebig, E.W.1    Wright, D.J.2    Rawal, B.D.3    Garrett, P.E.4    Schumacher, R.T.5
  • 10
    • 55649114213 scopus 로고    scopus 로고
    • SHIV- 1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys
    • Humbert M, Rasmussen RA, Song R, Ong H, Sharma P, et al. (2008) SHIV- 1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys. Retrovirology 5: 94.
    • (2008) Retrovirology , vol.5 , pp. 94
    • Humbert, M.1    Rasmussen, R.A.2    Song, R.3    Ong, H.4    Sharma, P.5
  • 11
    • 59749100246 scopus 로고    scopus 로고
    • Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection
    • Siddappa NB, Song R, Kramer VG, Chenine AL, Velu V, et al. (2009) Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection. J Virol 83: 1422-1432.
    • (2009) J Virol , vol.83 , pp. 1422-1432
    • Siddappa, N.B.1    Song, R.2    Kramer, V.G.3    Chenine, A.L.4    Velu, V.5
  • 12
    • 27944461010 scopus 로고    scopus 로고
    • Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant
    • Zhang H, Hoffmann F, He J, He X, Kankasa C, et al. (2005) Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology 2:67.
    • (2005) Retrovirology , vol.2 , pp. 67
    • Zhang, H.1    Hoffmann, F.2    He, J.3    He, X.4    Kankasa, C.5
  • 13
    • 34548232879 scopus 로고    scopus 로고
    • Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges
    • Rasmussen RA, Ong H, Song R, Chenine AL, Ayash-Rashkovsky M, et al. (2007) Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. AIDS 21: 1841-1848.
    • (2007) AIDS , vol.21 , pp. 1841-1848
    • Rasmussen, R.A.1    Ong, H.2    Song, R.3    Chenine, A.L.4    Ayash-Rashkovsky, M.5
  • 14
    • 0033856458 scopus 로고    scopus 로고
    • Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
    • Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, et al. (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74: 8358-8367.
    • (2000) J Virol , vol.74 , pp. 8358-8367
    • Derdeyn, C.A.1    Decker, J.M.2    Sfakianos, J.N.3    Wu, X.4    O'Brien, W.A.5
  • 15
    • 45849125030 scopus 로고    scopus 로고
    • Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays
    • Unit 12
    • Montefiori DC (2005) Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol Chapter 12: Unit 12 11.
    • (2005) Curr Protoc Immunol Chapter , vol.12 , pp. 11
    • Montefiori, D.C.1
  • 16
    • 77950196210 scopus 로고    scopus 로고
    • Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes
    • Chenine AL, Siddappa NB, Kramer VG, Sciaranghella G, Rasmussen RA, et al. (2010) Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes. J Infect Dis 201: 1155-1163.
    • (2010) J Infect Dis , vol.201 , pp. 1155-1163
    • Chenine, A.L.1    Siddappa, N.B.2    Kramer, V.G.3    Sciaranghella, G.4    Rasmussen, R.A.5
  • 17
    • 23244467373 scopus 로고    scopus 로고
    • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines
    • Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, et al. (2005) Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J Virol 79: 10103-10107.
    • (2005) J Virol , vol.79 , pp. 10103-10107
    • Mascola, J.R.1    D'Souza, P.2    Gilbert, P.3    Hahn, B.H.4    Haigwood, N.L.5
  • 18
    • 20944444788 scopus 로고    scopus 로고
    • Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines
    • Brown BK, Darden JM, Tovanabutra S, Oblander T, Frost J, et al. (2005) Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J Virol 79: 6089-6101.
    • (2005) J Virol , vol.79 , pp. 6089-6101
    • Brown, B.K.1    Darden, J.M.2    Tovanabutra, S.3    Oblander, T.4    Frost, J.5
  • 19
    • 65349196678 scopus 로고    scopus 로고
    • Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain
    • Wu L, Zhou T, Yang ZY, Svehla K, O'Dell S, et al. (2009) Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain. J Virol 83: 5077-5086.
    • (2009) J Virol , vol.83 , pp. 5077-5086
    • Wu, L.1    Zhou, T.2    Yang, Z.Y.3    Svehla, K.4    O'Dell, S.5
  • 20
    • 0034482696 scopus 로고    scopus 로고
    • Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates
    • Kwong PD, Wyatt R, Majeed S, Robinson J, Sweet RW, et al. (2000) Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 8: 1329-1339.
    • (2000) Structure , vol.8 , pp. 1329-1339
    • Kwong, P.D.1    Wyatt, R.2    Majeed, S.3    Robinson, J.4    Sweet, R.W.5
  • 21
    • 33750590099 scopus 로고    scopus 로고
    • AIDS vaccine development and challenge viruses: Getting real
    • Vlasak J, Ruprecht RM (2006) AIDS vaccine development and challenge viruses: getting real. Aids 20: 2135-2140.
    • (2006) Aids , vol.20 , pp. 2135-2140
    • Vlasak, J.1    Ruprecht, R.M.2
  • 23
    • 77949409948 scopus 로고    scopus 로고
    • Targeting early infection to prevent HIV-1 mucosal transmission
    • Haase AT (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217-223.
    • (2010) Nature , vol.464 , pp. 217-223
    • Haase, A.T.1
  • 24
    • 70349686331 scopus 로고    scopus 로고
    • Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
    • Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, et al. (2009) Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog 5: e1000598.
    • (2009) PLoS Pathog , vol.5
    • Moore, P.L.1    Ranchobe, N.2    Lambson, B.E.3    Gray, E.S.4    Cave, E.5
  • 25
    • 70349695689 scopus 로고    scopus 로고
    • Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways
    • Rong R, Li B, Lynch RM, Haaland RE, Murphy MK, et al. (2009) Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 5: e1000594.
    • (2009) PLoS Pathog , vol.5
    • Rong, R.1    Li, B.2    Lynch, R.M.3    Haaland, R.E.4    Murphy, M.K.5
  • 27
    • 0026544650 scopus 로고
    • Autologous HIV-1 neutralizing antibodies: Emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies
    • Arendrup M, Nielsen C, Hansen JE, Pedersen C, Mathiesen L, et al. (1992) Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr 5: 303-307.
    • (1992) J Acquir Immune Defic Syndr , vol.5 , pp. 303-307
    • Arendrup, M.1    Nielsen, C.2    Hansen, J.E.3    Pedersen, C.4    Mathiesen, L.5
  • 28
    • 0033046857 scopus 로고    scopus 로고
    • Neutralization escape in human immunodeficiency virus type 1-infected longterm nonprogressors
    • Bradney AP, Scheer S, Crawford JM, Buchbinder SP, Montefiori DC (1999) Neutralization escape in human immunodeficiency virus type 1-infected longterm nonprogressors. J Infect Dis 179: 1264-1267.
    • (1999) J Infect Dis , vol.179 , pp. 1264-1267
    • Bradney, A.P.1    Scheer, S.2    Crawford, J.M.3    Buchbinder, S.P.4    Montefiori, D.C.5
  • 29
    • 49149118421 scopus 로고    scopus 로고
    • Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
    • Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H (2008) Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 82: 7932-7941.
    • (2008) J Virol , vol.82 , pp. 7932-7941
    • Bunnik, E.M.1    Pisas, L.2    van Nuenen, A.C.3    Schuitemaker, H.4
  • 30
    • 0038002094 scopus 로고    scopus 로고
    • A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1
    • Geffin R, Hutto C, Andrew C, Scott GB (2003) A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1. Virology 310: 207-215.
    • (2003) Virology , vol.310 , pp. 207-215
    • Geffin, R.1    Hutto, C.2    Andrew, C.3    Scott, G.B.4
  • 31
    • 34648816125 scopus 로고    scopus 로고
    • N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
    • Gray ES, Moore PL, Pantophlet RA, Morris L (2007) N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization. J Virol 81: 10769-10776.
    • (2007) J Virol , vol.81 , pp. 10769-10776
    • Gray, E.S.1    Moore, P.L.2    Pantophlet, R.A.3    Morris, L.4
  • 32
    • 33646751914 scopus 로고    scopus 로고
    • Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1
    • Li B, Decker JM, Johnson RW, Bibollet-Ruche F, Wei X, et al. (2006) Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 80: 5211-5218.
    • (2006) J Virol , vol.80 , pp. 5211-5218
    • Li, B.1    Decker, J.M.2    Johnson, R.W.3    Bibollet-Ruche, F.4    Wei, X.5
  • 33
    • 0347579837 scopus 로고    scopus 로고
    • Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual
    • Montefiori DC, Altfeld M, Lee PK, Bilska M, Zhou J, et al. (2003) Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual. J Immunol 170: 3906-3914.
    • (2003) J Immunol , vol.170 , pp. 3906-3914
    • Montefiori, D.C.1    Altfeld, M.2    Lee, P.K.3    Bilska, M.4    Zhou, J.5
  • 34
    • 0037389643 scopus 로고    scopus 로고
    • Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    • Richman DD, Wrin T, Little SJ, Petropoulos CJ (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 100: 4144-4149.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4144-4149
    • Richman, D.D.1    Wrin, T.2    Little, S.J.3    Petropoulos, C.J.4
  • 35
    • 0025161606 scopus 로고
    • Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera
    • Tremblay M, Wainberg MA (1990) Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J Infect Dis 162: 735-737.
    • (1990) J Infect Dis , vol.162 , pp. 735-737
    • Tremblay, M.1    Wainberg, M.A.2
  • 36
    • 0037456827 scopus 로고    scopus 로고
    • Antibody neutralization and escape by HIV-1
    • Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
    • (2003) Nature , vol.422 , pp. 307-312
    • Wei, X.1    Decker, J.M.2    Wang, S.3    Hui, H.4    Kappes, J.C.5
  • 37
    • 30344476119 scopus 로고    scopus 로고
    • Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques
    • Blay WM, Gnanakaran S, Foley B, Doria-Rose NA, Korber BT, et al. (2006) Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. J Virol 80: 999-1014.
    • (2006) J Virol , vol.80 , pp. 999-1014
    • Blay, W.M.1    Gnanakaran, S.2    Foley, B.3    Doria-Rose, N.A.4    Korber, B.T.5
  • 38
    • 0033033625 scopus 로고    scopus 로고
    • Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
    • Cheng-Mayer C, Brown A, Harouse J, Luciw PA, Mayer AJ (1999) Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 73: 5294-5300.
    • (1999) J Virol , vol.73 , pp. 5294-5300
    • Cheng-Mayer, C.1    Brown, A.2    Harouse, J.3    Luciw, P.A.4    Mayer, A.J.5
  • 39
    • 37848999666 scopus 로고    scopus 로고
    • The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen
    • Ching LK, Vlachogiannis G, Bosch KA, Stamatatos L (2008) The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen. J Virol 82: 949-956.
    • (2008) J Virol , vol.82 , pp. 949-956
    • Ching, L.K.1    Vlachogiannis, G.2    Bosch, K.A.3    Stamatatos, L.4
  • 40
    • 0032849335 scopus 로고    scopus 로고
    • Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo
    • Etemad-Moghadam B, Sun Y, Nicholson EK, Karlsson GB, Schenten D, et al. (1999) Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo. J Virol 73: 8873-8879.
    • (1999) J Virol , vol.73 , pp. 8873-8879
    • Etemad-Moghadam, B.1    Sun, Y.2    Nicholson, E.K.3    Karlsson, G.B.4    Schenten, D.5
  • 41
    • 34249952292 scopus 로고    scopus 로고
    • Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
    • Kraft Z, Derby NR, McCaffrey RA, Niec R, Blay WM, et al. (2007) Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 81: 6402-6411.
    • (2007) J Virol , vol.81 , pp. 6402-6411
    • Kraft, Z.1    Derby, N.R.2    McCaffrey, R.A.3    Niec, R.4    Blay, W.M.5
  • 42
    • 55549132282 scopus 로고    scopus 로고
    • Importance of the V1/ V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response
    • Laird ME, Igarashi T, Martin MA, Desrosiers RC (2008) Importance of the V1/ V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response. J Virol 82: 11054-11065.
    • (2008) J Virol , vol.82 , pp. 11054-11065
    • Laird, M.E.1    Igarashi, T.2    Martin, M.A.3    Desrosiers, R.C.4
  • 43
    • 0034467915 scopus 로고    scopus 로고
    • Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo
    • Ye Y, Si ZH, Moore JP, Sodroski J (2000) Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo. J Virol 74: 11955-11962.
    • (2000) J Virol , vol.74 , pp. 11955-11962
    • Ye, Y.1    Si, Z.H.2    Moore, J.P.3    Sodroski, J.4
  • 44
    • 0030842609 scopus 로고    scopus 로고
    • Specific N-linked and Olinked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
    • Chackerian B, Rudensey LM, Overbaugh J (1997) Specific N-linked and Olinked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol 71: 7719-7727.
    • (1997) J Virol , vol.71 , pp. 7719-7727
    • Chackerian, B.1    Rudensey, L.M.2    Overbaugh, J.3
  • 45
    • 11144233210 scopus 로고    scopus 로고
    • Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking
    • Krachmarov C, Pinter A, Honnen WJ, Gorny MK, Nyambi PN, et al. (2005) Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking. J Virol 79: 780-790.
    • (2005) J Virol , vol.79 , pp. 780-790
    • Krachmarov, C.1    Pinter, A.2    Honnen, W.J.3    Gorny, M.K.4    Nyambi, P.N.5
  • 46
    • 33745796735 scopus 로고    scopus 로고
    • Factors determining the breadth and potency of neutralization by V3- specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1
    • Krachmarov CP, Honnen WJ, Kayman SC, Gorny MK, Zolla-Pazner S, et al. (2006) Factors determining the breadth and potency of neutralization by V3- specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. J Virol 80: 7127-7135.
    • (2006) J Virol , vol.80 , pp. 7127-7135
    • Krachmarov, C.P.1    Honnen, W.J.2    Kayman, S.C.3    Gorny, M.K.4    Zolla-Pazner, S.5
  • 47
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659.
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5
  • 48
    • 2342644898 scopus 로고    scopus 로고
    • The V1/ V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection
    • Pinter A, Honnen WJ, He Y, Gorny MK, Zolla-Pazner S, et al. (2004) The V1/ V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J Virol 78: 5205-5215.
    • (2004) J Virol , vol.78 , pp. 5205-5215
    • Pinter, A.1    Honnen, W.J.2    He, Y.3    Gorny, M.K.4    Zolla-Pazner, S.5
  • 49
    • 33748925430 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
    • Sagar M, Wu X, Lee S, Overbaugh J (2006) Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 80: 9586-9598.
    • (2006) J Virol , vol.80 , pp. 9586-9598
    • Sagar, M.1    Wu, X.2    Lee, S.3    Overbaugh, J.4
  • 50
    • 0029119783 scopus 로고
    • Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding
    • Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, et al. (1995) Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 69: 5723-5733.
    • (1995) J Virol , vol.69 , pp. 5723-5733
    • Wyatt, R.1    Moore, J.2    Accola, M.3    Desjardin, E.4    Robinson, J.5
  • 51
    • 33846552274 scopus 로고    scopus 로고
    • Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection
    • Rong R, Bibollet-Ruche F, Mulenga J, Allen S, Blackwell JL, et al. (2007) Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol 81: 1350-1359.
    • (2007) J Virol , vol.81 , pp. 1350-1359
    • Rong, R.1    Bibollet-Ruche, F.2    Mulenga, J.3    Allen, S.4    Blackwell, J.L.5
  • 52
    • 0038618737 scopus 로고    scopus 로고
    • A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12
    • Zwick MB, Kelleher R, Jensen R, Labrijn AF, Wang M, et al. (2003) A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. J Virol 77: 6965-6978.
    • (2003) J Virol , vol.77 , pp. 6965-6978
    • Zwick, M.B.1    Kelleher, R.2    Jensen, R.3    Labrijn, A.F.4    Wang, M.5
  • 53
    • 4644342929 scopus 로고    scopus 로고
    • CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    • Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759.
    • (2004) J Exp Med , vol.200 , pp. 749-759
    • Brenchley, J.M.1    Schacker, T.W.2    Ruff, L.E.3    Price, D.A.4    Taylor, J.H.5
  • 54
    • 0031903088 scopus 로고    scopus 로고
    • Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection
    • Mattapallil JJ, Smit-McBride Z, McChesney M, Dandekar S (1998) Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection. J Virol 72: 6421-6429.
    • (1998) J Virol , vol.72 , pp. 6421-6429
    • Mattapallil, J.J.1    Smit-McBride, Z.2    McChesney, M.3    Dandekar, S.4
  • 55
    • 0032540418 scopus 로고    scopus 로고
    • Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
    • Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
    • (1998) Science , vol.280 , pp. 427-431
    • Veazey, R.S.1    DeMaria, M.2    Chalifoux, L.V.3    Shvetz, D.E.4    Pauley, D.R.5
  • 56
    • 1242342134 scopus 로고    scopus 로고
    • Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques
    • Balfe P, Shapiro S, Hsu M, Buckner C, Harouse JM, et al. (2004) Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques. Virology 318: 267-279.
    • (2004) Virology , vol.318 , pp. 267-279
    • Balfe, P.1    Shapiro, S.2    Hsu, M.3    Buckner, C.4    Harouse, J.M.5
  • 57
    • 0033617547 scopus 로고    scopus 로고
    • Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
    • Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C (1999) Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284: 816-819.
    • (1999) Science , vol.284 , pp. 816-819
    • Harouse, J.M.1    Gettie, A.2    Tan, R.C.3    Blanchard, J.4    Cheng-Mayer, C.5
  • 58
    • 0033176826 scopus 로고    scopus 로고
    • In vivo adaptation of SHIV(SF162): Chimeric virus expressing a NSI, CCR5-specific envelope protein
    • Tan RC, Harouse JM, Gettie A, Cheng-Mayer C (1999) In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein. J Med Primatol 28: 164-168.
    • (1999) J Med Primatol , vol.28 , pp. 164-168
    • Tan, R.C.1    Harouse, J.M.2    Gettie, A.3    Cheng-Mayer, C.4
  • 59
    • 0034284924 scopus 로고    scopus 로고
    • Sensitive and robust one-tube real-time reverse transcriptasepolymerase chain reaction to quantify SIV RNA load: Comparison of one- versus two-enzyme systems
    • Hofmann-Lehmann R, Swenerton RK, Liska V, Leutenegger CM, Lutz H, et al. (2000) Sensitive and robust one-tube real-time reverse transcriptasepolymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses 16: 1247-1257.
    • (2000) AIDS Res Hum Retroviruses , vol.16 , pp. 1247-1257
    • Hofmann-Lehmann, R.1    Swenerton, R.K.2    Liska, V.3    Leutenegger, C.M.4    Lutz, H.5
  • 60
    • 23844524271 scopus 로고    scopus 로고
    • Highly sensitive SIV plasma viral load assay: Practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS
    • Cline AN, Bess JW, Piatak M, Jr., Lifson JD (2005) Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 34: 303-312.
    • (2005) J Med Primatol , vol.34 , pp. 303-312
    • Cline, A.N.1    Bess, J.W.2    Piatak Jr., M.3    Lifson, J.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.